For 2020 the following Registry fellowships will be available in the ERA Registry office in the Amsterdam University Medical Center:
Research registry fellowships to support Registry related activities of the association (e.g. ERA Registry, ESPN/ERA Registry, EURODOPPS).
Duration: from a minimum of 4 weeks (28 days) to a maximum of 6 weeks (42 days).
Nephrologist or nephrology researcher <40 years of age from the ERA geographic area.*
The candidate will be selected by a small committee selected by the ERA Registry and then approved by the ERA Council. In case of doubt the SAB (Chair; Co-Chair and Secretary-Coordinator) will be consulted.
Fellowships have the aim of scientific publication.
Fellows will be supervised by members of the Registry staff.
The Call is opened from March 5, 2020 and will close on April 7, 2020 (the deadline for submitting an application). To submit your fellowship request you must fill in the online form which can be found on the ERA website (available from March 5, 2020). For the complete instructions and rules please read the “ERA Young Fellowship General Rules”.
* Geographical area of ERA, including all European countries and countries bordering Europe and the Mediterranean Sea: Albania, Algeria, Andorra, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, FYRM of Macedonia, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kosovo*, Latvia, Lebanon, Libya, Liechtenstein, Lithuania, Luxembourg, Malta, Moldova, Monaco, Montenegro, Morocco, The Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovak Republic, Slovenia, Spain, Switzerland, Sweden, Syria, Tunisia, Turkey, Ukraine, United Kingdom. (*) This designation is without prejudice to positions on status, and is in line with UNSCR 1244/99 and the ICJ Opinion on the Kosovo declaration of independence.
Department of Medical Informatics
Amsterdam University Medical Centers, location AMC
Follow us on: Twitter